Powered-assisted partial turbinectomy versus mometasone furoate nasal spray for relief of nasal blockage in chronic or idiopathic rhinosinusitis

Acta Otolaryngol. 2011 Dec;131(12):1286-92. doi: 10.3109/00016489.2011.615068. Epub 2011 Sep 12.


Conclusion: Power-assisted turbinectomy is a safe and reliable alternative for patients with nasal blockage if nasal corticosteroid spray therapy is not suitable.

Objective: Powered-assisted partial turbinectomy was compared to the use of a corticosteroid nasal spray for relief of nasal obstruction in chronic or idiopathic rhinosinusitis.

Methods: Patients were randomized to either power-assisted partial turbinectomy or daily use of mometasone furoate nasal spray for 6 months. Evaluation by peak nasal inspiratory flow (PNIF) and grading of symptoms by use of visual analog scale was done after 3 and 6 months. Grading of symptoms was also done by use of a questionnaire approximately 30 months after the last visit.

Results: PNIF scores improved for all patients, although significantly only for patients on mometasone spray. Patients' self-reported symptoms decreased more for operated patients. Side effects were few and mild in both groups.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents / therapeutic use*
  • Chronic Disease
  • Female
  • Humans
  • Inspiratory Capacity
  • Male
  • Middle Aged
  • Mometasone Furoate
  • Mouth Breathing
  • Multivariate Analysis
  • Nasal Obstruction / etiology
  • Nasal Obstruction / therapy*
  • Nasal Sprays*
  • Pregnadienediols / therapeutic use*
  • Quality of Life
  • Rhinitis / complications
  • Rhinitis / therapy
  • Severity of Illness Index
  • Sinusitis / complications
  • Sinusitis / therapy
  • Smell
  • Turbinates / surgery*
  • Young Adult


  • Anti-Inflammatory Agents
  • Nasal Sprays
  • Pregnadienediols
  • Mometasone Furoate